X4 Pharmaceuticals - Stock Price History | XFOR

Historical daily share price chart and data for X4 Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for X4 Pharmaceuticals as of September 27, 2021 is 5.57.
  • The all-time high X4 Pharmaceuticals stock closing price was 22.98 on March 21, 2019.
  • The X4 Pharmaceuticals 52-week high stock price is 10.70, which is 92.1% above the current share price.
  • The X4 Pharmaceuticals 52-week low stock price is 4.25, which is 23.7% below the current share price.
  • The average X4 Pharmaceuticals stock price for the last 52 weeks is 7.29.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
X4 Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 8.2683 10.9500 11.0100 5.4100 6.4300 -39.91%
2019 14.6774 15.1900 22.9800 9.9300 10.7000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.138B $0.003B
X4 Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases. The company's product candidates include X4P-001, X4P-002 and X4P-003 which are in clinical stage. X4 Pharmaceuticals Inc., formerly known as Arsanis, Inc., is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29